Office of Biotechnology Activities, Office of Science Policy, Office of the Director, Notice of Meeting, 32992 [06-5150]

Download as PDF 32992 Federal Register / Vol. 71, No. 109 / Wednesday, June 7, 2006 / Notices property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute on Alcohol Abuse and Alcoholism Special Emphasis Panel, Loan Repayment Program. Date: June 6, 2006. Time: 1 p.m. to 3:30 p.m. Agenda: To review and evaluate grant applications. Place: National Institute of Health, 5635 Fishers Lane, Bethesda, MD 20892 (Telephone Conference Call). Contact Person: Katrina L. Foster, Ph.D., Scientific Review Administrator, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, 5636 Fishers Lane, Rm. 3042, Rockville, MD 20852. 301 443—4032. katrina@mail.nih.gov. This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. (Catalogue of Federal Domestic Assistance Program Nos. 93.271, Alcohol Research Career Development Awards for Scientists and Clinicians; 93.272, Alcohol National Research Service Awards for Research Training; 93.273, Alcohol Research Programs; 93.891, Alcohol Research Center Grants, National Institutes of Health, HHS) Dated: May 31, 2006. Anna Snouffer, Acting Director, Office of Federal Advisory Committee Policy. [FR Doc. 06–5157 Filed 6–6–06; 8:45 am] BILLING CODE 4140–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health rwilkins on PROD1PC63 with NOTICES Office of Biotechnology Activities, Office of Science Policy, Office of the Director, Notice of Meeting Pursuant to section 10(a) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the meeting of the National Science Advisory Board for Biosecurity (NSABB). Under authority 42 U.S.C. 217a, section 222 of the Public Health Service Act, as amended, the Department of Health and Human Services established NSABB to provide advice, guidance and leadership regarding federal oversight of dual use research, defined as biological research with legitimate scientific purpose that could be misused to pose a biological threat to public health and/ or national security. The meeting will be open the public, however pre-registration is strongly recommended due to space limitations. VerDate Aug<31>2005 17:54 Jun 06, 2006 Jkt 208001 Persons planning to attend should register online at https:// www.biosecurityboard.gov/meetings.asp or by calling Capitol Consulting Corporation (Contact: Saundra M. Bromberg), at 301–468–6004, ext. 406. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should indicate these requirements upon registration. Name of Committee: National Advisory Board for Biosecurity. Date: July 13, 2006. Open: 8 a.m. to 6 p.m. Agenda: Presentations and discussions regarding: (1) Criteria for defining dual use research in the life sciences; (2) the role of a code of conduct for the life sciences; (3) communications of dual use research; (4) international perspectives on dual use research; (5) public comments; and (6) and other business of the Board. Place: The National Institutes of Health, 31 Center Drive, Building 31, 6C—Room 10, Bethesda, Maryland 20892. Contact Person: Laurie Lelwallen, NSABB Program Assistant, 6705 Rockledge Drive, Bethesda, Maryland 20892, (301) 496–9838. This meeting will also be Webcast. The draft meeting agenda and other information about NSABB, including information about access to the Webcast and pre-registration, will be available at https:// www.biosecurityboard.gov/meetings.asp. Any member of the public interested in presenting oral comments at the meeting may notify the Contact Person listed on this notice at least 10 days in advance of the meeting. Interested individuals and representatives of an organization may submit a letter of intent, a brief description of the organization represented and a short description of the oral presentation. Only one representative of an organization may be allowed to present oral comments. Both printed and electronic copies are requested for the record. In addition, any interested person may file written comments with the committee. All written comments must be received by June 30, 2006 and should be sent via e-mail to nsabb@od.nih.gov with ‘‘NSABB Public Comment’’ as the subject line or by regular mail to 6705 Rockledge Drive, Suite 750, Bethesda, MD 20892, Attention Laurie Lewallen. The statement should include the name, address, telephone number and, when applicable, the business or professional affiliation of the interested person. In the interest of security, NIH has instituted stringent procedures for entrance onto the NIH campus. All visitor vehicles, including taxicabs, hotel and airport shuttles will be inspected before being allowed on campus. Visitors will be asked to show one form of identification (for example, government-issued photo ID, driver’s license, or passport) and to state the purpose of their visit. PO 00000 Frm 00080 Fmt 4703 Sfmt 4703 Dated: May 21, 2006. Anna Snouffer, Acting Director, Office of Federal Advisory Committee Policy. [FR Doc. 06–5150 Filed 6–6–06; 8:45 am] BILLING CODE 4140–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Center for Scientific Review; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Center for Scientific Review Special Emphasis Panel; B&T Cell Development and Evolution. Date: June 15, 2006. Time: 11 a.m. to 1 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 (Telephone Conference Call). Contact Person: Betty Hayden, PhD, Scientific Review Administrator, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4206, MSC 7812, Bethesda, MD 20892. 301–435– 1223. haydenb@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; HAI Overflow Special Emphasis Panel Review. Date: June 22, 2006. Time: 8:30 a.m. to 4 p.m. Agenda: To review and evaluate grant applications. Place: The Watergate, 2650 Virginia Avenue, NW., Washington, DC 20037. Contact Person: Jin Huang, PhD, Scientific Review Administrator, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4095G, MSC 7812, Bethesda, MD 20892. 301–435–1187. jh377p@nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel, Risk and Substance Abuse. Date: June 22, 2006. Time: 9 a.m. to 11 a.m. Agenda: To review and evaluate grant applications. E:\FR\FM\07JNN1.SGM 07JNN1

Agencies

[Federal Register Volume 71, Number 109 (Wednesday, June 7, 2006)]
[Notices]
[Page 32992]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 06-5150]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Office of Biotechnology Activities, Office of Science Policy, 
Office of the Director, Notice of Meeting

    Pursuant to section 10(a) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the meeting of 
the National Science Advisory Board for Biosecurity (NSABB).
    Under authority 42 U.S.C. 217a, section 222 of the Public Health 
Service Act, as amended, the Department of Health and Human Services 
established NSABB to provide advice, guidance and leadership regarding 
federal oversight of dual use research, defined as biological research 
with legitimate scientific purpose that could be misused to pose a 
biological threat to public health and/or national security.
    The meeting will be open the public, however pre-registration is 
strongly recommended due to space limitations. Persons planning to 
attend should register online at https://www.biosecurityboard.gov/
meetings.asp or by calling Capitol Consulting Corporation (Contact: 
Saundra M. Bromberg), at 301-468-6004, ext. 406. Individuals who plan 
to attend and need special assistance, such as sign language 
interpretation or other reasonable accommodations, should indicate 
these requirements upon registration.

    Name of Committee: National Advisory Board for Biosecurity.
    Date: July 13, 2006.
    Open: 8 a.m. to 6 p.m.
    Agenda: Presentations and discussions regarding: (1) Criteria 
for defining dual use research in the life sciences; (2) the role of 
a code of conduct for the life sciences; (3) communications of dual 
use research; (4) international perspectives on dual use research; 
(5) public comments; and (6) and other business of the Board.
    Place: The National Institutes of Health, 31 Center Drive, 
Building 31, 6C--Room 10, Bethesda, Maryland 20892.
    Contact Person: Laurie Lelwallen, NSABB Program Assistant, 6705 
Rockledge Drive, Bethesda, Maryland 20892, (301) 496-9838.
    This meeting will also be Webcast. The draft meeting agenda and 
other information about NSABB, including information about access to 
the Webcast and pre-registration, will be available at https://
www.biosecurityboard.gov/meetings.asp.
    Any member of the public interested in presenting oral comments 
at the meeting may notify the Contact Person listed on this notice 
at least 10 days in advance of the meeting. Interested individuals 
and representatives of an organization may submit a letter of 
intent, a brief description of the organization represented and a 
short description of the oral presentation. Only one representative 
of an organization may be allowed to present oral comments. Both 
printed and electronic copies are requested for the record. In 
addition, any interested person may file written comments with the 
committee. All written comments must be received by June 30, 2006 
and should be sent via e-mail to nsabb@od.nih.gov with ``NSABB 
Public Comment'' as the subject line or by regular mail to 6705 
Rockledge Drive, Suite 750, Bethesda, MD 20892, Attention Laurie 
Lewallen. The statement should include the name, address, telephone 
number and, when applicable, the business or professional 
affiliation of the interested person.
    In the interest of security, NIH has instituted stringent 
procedures for entrance onto the NIH campus. All visitor vehicles, 
including taxicabs, hotel and airport shuttles will be inspected 
before being allowed on campus. Visitors will be asked to show one 
form of identification (for example, government-issued photo ID, 
driver's license, or passport) and to state the purpose of their 
visit.

    Dated: May 21, 2006.
Anna Snouffer,
Acting Director, Office of Federal Advisory Committee Policy.
[FR Doc. 06-5150 Filed 6-6-06; 8:45 am]
BILLING CODE 4140-01-M
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.